FBTCX vs. FHCCX
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Fidelity Advisor Health Care Fund Class C (FHCCX).
FBTCX is managed by Fidelity. It was launched on Dec 27, 2000. FHCCX is managed by Fidelity. It was launched on Nov 3, 1997.
Performance
FBTCX vs. FHCCX - Performance Comparison
Loading graphics...
FBTCX vs. FHCCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBTCX Fidelity Advisor Biotechnology Fund Class C | -2.86% | 38.48% | -2.00% | 9.86% | -8.64% | -3.72% | 31.17% | 24.82% | -4.55% | 24.81% |
FHCCX Fidelity Advisor Health Care Fund Class C | -9.80% | -5.49% | 3.20% | 3.02% | -13.72% | 10.43% | 20.15% | 26.96% | 6.37% | 23.12% |
Returns By Period
In the year-to-date period, FBTCX achieves a -2.86% return, which is significantly higher than FHCCX's -9.80% return. Over the past 10 years, FBTCX has outperformed FHCCX with an annualized return of 9.77%, while FHCCX has yielded a comparatively lower 5.57% annualized return.
FBTCX
- 1D
- -0.75%
- 1M
- -6.13%
- YTD
- -2.86%
- 6M
- 10.98%
- 1Y
- 41.66%
- 3Y*
- 15.08%
- 5Y*
- 5.77%
- 10Y*
- 9.77%
FHCCX
- 1D
- -0.72%
- 1M
- -9.58%
- YTD
- -9.80%
- 6M
- -16.82%
- 1Y
- -13.69%
- 3Y*
- -3.33%
- 5Y*
- -3.13%
- 10Y*
- 5.57%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBTCX vs. FHCCX - Expense Ratio Comparison
FBTCX has a 1.75% expense ratio, which is higher than FHCCX's 1.72% expense ratio.
Return for Risk
FBTCX vs. FHCCX — Risk / Return Rank
FBTCX
FHCCX
FBTCX vs. FHCCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Fidelity Advisor Health Care Fund Class C (FHCCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBTCX | FHCCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.52 | -0.56 | +2.08 |
Sortino ratioReturn per unit of downside risk | 2.06 | -0.55 | +2.61 |
Omega ratioGain probability vs. loss probability | 1.26 | 0.90 | +0.36 |
Calmar ratioReturn relative to maximum drawdown | 2.31 | -0.55 | +2.86 |
Martin ratioReturn relative to average drawdown | 9.25 | -1.35 | +10.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBTCX | FHCCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.52 | -0.56 | +2.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.25 | -0.16 | +0.41 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.29 | +0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.26 | 0.45 | -0.19 |
Correlation
The correlation between FBTCX and FHCCX is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FBTCX vs. FHCCX - Dividend Comparison
FBTCX's dividend yield for the trailing twelve months is around 1.73%, while FHCCX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBTCX Fidelity Advisor Biotechnology Fund Class C | 1.73% | 1.68% | 0.00% | 0.00% | 0.00% | 24.50% | 9.78% | 7.92% | 2.92% | 0.00% | 0.00% | 5.73% |
FHCCX Fidelity Advisor Health Care Fund Class C | 0.00% | 0.00% | 17.59% | 0.00% | 0.00% | 8.32% | 6.85% | 0.41% | 6.43% | 0.00% | 0.00% | 7.84% |
Drawdowns
FBTCX vs. FHCCX - Drawdown Comparison
The maximum FBTCX drawdown since its inception was -64.04%, which is greater than FHCCX's maximum drawdown of -45.28%. Use the drawdown chart below to compare losses from any high point for FBTCX and FHCCX.
Loading graphics...
Drawdown Indicators
| FBTCX | FHCCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.04% | -45.28% | -18.76% |
Max Drawdown (1Y)Largest decline over 1 year | -13.63% | -27.25% | +13.62% |
Max Drawdown (5Y)Largest decline over 5 years | -37.26% | -29.67% | -7.59% |
Max Drawdown (10Y)Largest decline over 10 years | -39.37% | -29.67% | -9.70% |
Current DrawdownCurrent decline from peak | -7.46% | -27.25% | +19.79% |
Average DrawdownAverage peak-to-trough decline | -23.21% | -10.12% | -13.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.16% | 11.08% | -6.92% |
Volatility
FBTCX vs. FHCCX - Volatility Comparison
Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a higher volatility of 7.76% compared to Fidelity Advisor Health Care Fund Class C (FHCCX) at 5.59%. This indicates that FBTCX's price experiences larger fluctuations and is considered to be riskier than FHCCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBTCX | FHCCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.76% | 5.59% | +2.17% |
Volatility (6M)Calculated over the trailing 6-month period | 16.37% | 22.17% | -5.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.57% | 25.40% | +0.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.40% | 19.34% | +4.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.62% | 19.55% | +5.07% |